NEW DELHI : Hyderabad-based pharma company Biological E. Limited (BE) on Saturday announced that its Covid-19 vaccine CORBEVAX has been approved by the Drug Controller General of India (DCGI) as a heterologous Covid-19 booster dose for adults.
Now, individuals aged 18 years and above who have already taken two doses of either Covishield or Covaxin can now receive a dose of Corbevax as a heterologous Covid-19 booster With this development, BE’s vaccine has become the first in India to be approved as a heterologous Covid-19 booster.
Recently, BE has furnished its clinical trials data to the DCGI who after a detailed evaluation and deliberations with Subject Experts Committee, granted their approval for administering the Corbevax vaccine as a heterologous booster dose to people who have already taken two doses of either Covishield or Covaxin.
BE’s clinical trial data showed that the vaccine provided significant enhancement in immune response and excellent safety profile required for an effective booster.